Sagimet Biosciences Inc. Series A Common Stock (SGMT) Live Share Price, Invest From India

Sagimet Biosciences Inc. Series A Common Stock Stock Performance

as on May 7, 2026 at 6:18 pm IST

Day's Low
$7.54
Day's Price Range
$8.38
$8.38
10.02%
Downside
52 Week's Low
52 Week's High
$3.08
52-Week Price Range
$11.41
$8.38
63.25%
Downside
36.16%
Upside

Sagimet Biosciences Inc. Series A Common Stock share price movements today

Previous Close: $7.72
Open: $7.76
Volume: 1.8M
Day's Low - High: $7.54 - $8.38
52 Week Low - High: $3.08 - $11.41

Sagimet Biosciences Inc. Series A Common Stock Historical Returns

1 Month Return: + 64.96 %
3 Month Return: + 50.99 %
1 Year Return: + 150.9 %
3 Year Return: 0 %
5 Year Return: 0 %

Sagimet Biosciences Inc. Series A Common Stock Stock Fundamentals & Key Indicators

Check Sagimet Biosciences Inc. Series A Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$517.5M

EPS (TTM)

-1.3286

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-38.20%

Sagimet Biosciences Inc. Series A Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sagimet Biosciences Inc. Series A Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sagimet Biosciences Inc. Series A Common Stock	BUY	$517.5M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Sagimet Biosciences Inc. Series A Common Stock Stock including INR - Dollar returns

The Sagimet Biosciences Inc. Series A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Sagimet Biosciences Inc. Series A Common Stock investment value today

Current value as on today

₹2,81,567

Returns

₹1,81,567

(+181.57%)

Returns from Sagimet Biosciences Inc. Series A Common Stock Stock

₹1,50,898 (+150.9%)

Dollar Impact

₹30,668 (+30.67%)

Analyst Recommendation on Sagimet Biosciences Inc. Series A Common Stock Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Sagimet Biosciences Inc. Series A Common Stock. Average target price of $28.5

Sagimet Biosciences Inc. Series A Common Stock Share Price Target

Get share price movements and forecasts by analysts on Sagimet Biosciences Inc. Series A Common Stock.

What analysts predicted

70.6%UPSIDE

Target Price

$28.5

Current Price

$8.38

Analyzed by

11 Analysts

Target

$28.50

Sagimet Biosciences Inc. Series A Common Stock target price $28.5, a slight upside of 70.6% compared to current price of $8.38. According to 11 analysts rating.

Indian Investors' Interest in Sagimet Biosciences Inc. Series A Common Stock Stock

Search interest for Sagimet Biosciences Inc. Series A Common Stock Stock has increased by 2213% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 7, 2026 to May 7, 2026

Change:2213% versus previous 30 day period

Sagimet Biosciences Inc. Series A Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	2	-	-	-	-	-	-	-	-	-
Gross Profit	2	-	-	-	-	-	-	-	-	-
Operating Income	-7	-9	-8	-10	-16	-18	-19	-11	-14	-10
EBITDA	-7	-6	-8	-10	-16	-16	-19	-11	-12	-12
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-8	-6	-8	-14	-16	-18	-10	-12	-9
Income Tax Expense	-1	-1	-8	-10	-	-	-	-	-	-
Net Income	-6	-8	-6	-8	-14	-16	-18	-10	-12	-9
Net Profit Margin	-317.65%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Sagimet Biosciences Inc. Series A Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	2	-	-
Gross Profit	0	0	0	0	2	-	-
Operating Income	-14	-11	-23	-31	-30	-54	-56
EBITDA	-14	-11	-23	-31	-30	-45	-56
Interest Expense	0	-	-	-	-	-	-
Depreciation	0	-	-	-	-	-	-
Income Before Tax	-14	-11	-24	-30	-27	-45	-51
Income Tax Expense	0	0	-23	-31	-2	-	-
Net Income	-14	-11	-24	-30	-27	-45	-51
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-1393.80%	0.00%	0.00%

Sagimet Biosciences Inc. Series A Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-6	-8	-14	-16	-18	-10	-12	-9
Operating Cash Flow	-7	-6	-5	-19	-11	-14	-9	-10	-11
Investing Cash Flow	-19	3	-75	0	9	3	-13	0	14
Financing Cash Flow	3	104	0	-	-	-	0	0	-
Change in Cash	-26	101	-80	-18	-1	-11	-22	-9	2

Sagimet Biosciences Inc. Series A Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-11	-24	-30	-27	-45	-51
Operating Cash Flow	-10	-21	-24	-23	-42	-45
Investing Cash Flow	0	-	-32	12	-61	4
Financing Cash Flow	68	9	0	86	104	0
Change in Cash	58	-11	-56	74	0	-40

Insights on Sagimet Biosciences Inc. Series A Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SGMT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, SGMT stock has moved up by 65.0%

About Sagimet Biosciences Inc. Series A Common Stock

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Organisation	Sagimet Biosciences Inc. Series A Common Stock
Headquarters	155 Bovet Road, San Mateo, CA, United States, 94402
Industry	Biotechnology
CEO	Mr. David A. Happel
E-voting on shares	Click here to vote

Key Management of Sagimet Biosciences Inc. Series A Common Stock

Name	Title
Mr. Robert D'Urso	Senior Vice President of New Products
Dr. Andreas Grauer M.D.	Chief Medical Officer
Mr. David A. Happel	CEO, President & Director
Ms. Elizabeth Rozek Esq., J.D.	Chief Legal & Administrative Officer
Mr. Urs Greber Ph.D.	Co-Founder
Dr. Lucas Pelkmans Ph.D.	Co-Founder
Mr. Thierry Chauche	CFO & Principal Accounting Officer
Dr. Marie O'Farrell Ph.D.	Chief Scientific Officer

FAQs

What is Sagimet Biosciences Inc. Series A Common Stock share price today?

Sagimet Biosciences Inc. Series A Common Stock share price today is $8.38 as on May 7, 2026 at 12:48 pm IST at the close of the market. Sagimet Biosciences Inc. Series A Common Stock share today touched a day high of $8.38 and a low of $7.54.

What is the 52 week high and 52 week low for Sagimet Biosciences Inc. Series A Common Stock share?

Sagimet Biosciences Inc. Series A Common Stock share touched a 52 week high of $11.41 on July 25, 2025 and a 52 week low of $3.08 on May 15, 2025. Sagimet Biosciences Inc. Series A Common Stock stock price today i.e. May 7, 2026 at 12:48 pm IST is closed at $8.38,which is 26.56% down from its 52 week high and 172.08% up from its 52 week low.

What is Sagimet Biosciences Inc. Series A Common Stock's market capitalisation today?

Sagimet Biosciences Inc. Series A Common Stock market capitalisation is $0.00T as on May 7, 2026 at 12:48 pm IST.

How to invest in Sagimet Biosciences Inc. Series A Common Stock Stock (SGMT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sagimet Biosciences Inc. Series A Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sagimet Biosciences Inc. Series A Common Stock Shares that will get you 0.1790 shares as per Sagimet Biosciences Inc. Series A Common Stock share price of $8.38 per share as on May 7, 2026 at 12:48 pm IST.

What is the minimum amount required to buy Sagimet Biosciences Inc. Series A Common Stock Stock (SGMT) from India?

Indian investors can start investing in Sagimet Biosciences Inc. Series A Common Stock (SGMT) shares with as little as ₹94.61 or $1 (as of May 7, 2026 at 3:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Sagimet Biosciences Inc. Series A Common Stock stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 3:42 pm IST). Based on Sagimet Biosciences Inc. Series A Common Stock share’s latest price of $8.38 as on May 7, 2026 at 12:48 pm IST, you will get 1.1933 shares of Sagimet Biosciences Inc. Series A Common Stock. Learn more about fractional shares .